Gene Page: IQCG
Summary ?
GeneID | 84223 |
Symbol | IQCG |
Synonyms | CFAP122|DRC9 |
Description | IQ motif containing G |
Reference | MIM:612477|HGNC:HGNC:25251|Ensembl:ENSG00000114473|HPRD:13746|Vega:OTTHUMG00000155408 |
Gene type | protein-coding |
Map location | 3q29 |
Pascal p-value | 0.09 |
Sherlock p-value | 0.01 |
Fetal beta | 0.053 |
eGene | Cerebellar Hemisphere Cerebellum Cortex Frontal Cortex BA9 Myers' cis & trans Meta |
Gene in Data Sources
Gene set name | Method of gene set | Description | Info |
---|---|---|---|
CV:PGCnp | Genome-wide Association Study | GWAS |
Section I. Genetics and epigenetics annotation
eQTL annotation
SNP ID | Chromosome | Position | eGene | Gene Entrez ID | pvalue | qvalue | TSS distance | eQTL type |
---|---|---|---|---|---|---|---|---|
rs6703905 | chr1 | 89656748 | IQCG | 84223 | 0.19 | trans | ||
rs6659821 | chr1 | 110339827 | IQCG | 84223 | 0 | trans | ||
rs1814902 | chr3 | 43251753 | IQCG | 84223 | 0.09 | trans | ||
rs9681394 | chr3 | 43256230 | IQCG | 84223 | 0.02 | trans | ||
rs4683367 | chr3 | 43257826 | IQCG | 84223 | 0.09 | trans | ||
rs7621511 | chr3 | 43279877 | IQCG | 84223 | 0.09 | trans | ||
rs6799944 | chr3 | 122905753 | IQCG | 84223 | 0.04 | trans | ||
rs1981925 | chr4 | 34348578 | IQCG | 84223 | 0.04 | trans | ||
rs2291715 | chr4 | 75485871 | IQCG | 84223 | 0.19 | trans | ||
rs4544747 | chr4 | 179527501 | IQCG | 84223 | 0.14 | trans | ||
rs6862696 | chr5 | 66724676 | IQCG | 84223 | 0.16 | trans | ||
rs2268637 | chr6 | 39050917 | IQCG | 84223 | 0.1 | trans | ||
rs17160028 | chr7 | 31292738 | IQCG | 84223 | 0.19 | trans | ||
rs10486710 | chr7 | 41315585 | IQCG | 84223 | 0.11 | trans | ||
rs38847 | chr7 | 116325325 | IQCG | 84223 | 0.1 | trans | ||
rs4923483 | chr11 | 27835749 | IQCG | 84223 | 0.07 | trans | ||
rs1491856 | chr11 | 27845988 | IQCG | 84223 | 0.05 | trans | ||
rs4923492 | chr11 | 27859181 | IQCG | 84223 | 0.12 | trans | ||
rs1352864 | chr11 | 27866782 | IQCG | 84223 | 0.02 | trans | ||
rs2638120 | chr11 | 27887392 | IQCG | 84223 | 0.02 | trans | ||
rs2638121 | chr11 | 27887421 | IQCG | 84223 | 0.01 | trans | ||
rs7117381 | chr11 | 27909690 | IQCG | 84223 | 0.05 | trans | ||
rs16954076 | chr13 | 98054591 | IQCG | 84223 | 0.12 | trans | ||
rs236517 | chr17 | 68275174 | IQCG | 84223 | 0.18 | trans | ||
rs16953782 | chr18 | 8564832 | IQCG | 84223 | 0.09 | trans | ||
rs16962554 | chr19 | 29590544 | IQCG | 84223 | 0.01 | trans | ||
rs7268640 | chr20 | 47150267 | IQCG | 84223 | 0.08 | trans | ||
rs8127083 | chr21 | 31690320 | IQCG | 84223 | 0.09 | trans | ||
rs7062071 | chrX | 17724830 | IQCG | 84223 | 0.06 | trans |
Section II. Transcriptome annotation
General gene expression (GTEx)
Gene expression during devlopment (BrainCloud)
Footnote:
A total of 269 time points ploted, with n=38 fetal samples (x=1:38). Each triangle represents one time point.
Gene expression of temporal and spatial changes (BrainSpan)
Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes the lower 25% and upper 25% of the expression distribution.
No co-expressed genes in brain regions
Section V. Pathway annotation
Pathway name | Pathway size | # SZGR 2.0 genes in pathway | Info |
---|---|---|---|
PARENT MTOR SIGNALING UP | 567 | 375 | All SZGR 2.0 genes in this pathway |
BERTUCCI MEDULLARY VS DUCTAL BREAST CANCER UP | 206 | 111 | All SZGR 2.0 genes in this pathway |
SENGUPTA NASOPHARYNGEAL CARCINOMA DN | 349 | 157 | All SZGR 2.0 genes in this pathway |
DAVICIONI MOLECULAR ARMS VS ERMS UP | 332 | 228 | All SZGR 2.0 genes in this pathway |
ZHOU INFLAMMATORY RESPONSE LIVE UP | 485 | 293 | All SZGR 2.0 genes in this pathway |
GINESTIER BREAST CANCER ZNF217 AMPLIFIED DN | 335 | 193 | All SZGR 2.0 genes in this pathway |
KIM WT1 TARGETS UP | 214 | 155 | All SZGR 2.0 genes in this pathway |
DODD NASOPHARYNGEAL CARCINOMA UP | 1821 | 933 | All SZGR 2.0 genes in this pathway |
GAUSSMANN MLL AF4 FUSION TARGETS A DN | 90 | 61 | All SZGR 2.0 genes in this pathway |
NAKAMURA LUNG CANCER DIFFERENTIATION MARKERS | 14 | 5 | All SZGR 2.0 genes in this pathway |
EBAUER TARGETS OF PAX3 FOXO1 FUSION DN | 48 | 31 | All SZGR 2.0 genes in this pathway |
CREIGHTON ENDOCRINE THERAPY RESISTANCE 2 | 473 | 224 | All SZGR 2.0 genes in this pathway |
SMID BREAST CANCER BASAL UP | 648 | 398 | All SZGR 2.0 genes in this pathway |
MARTENS TRETINOIN RESPONSE DN | 841 | 431 | All SZGR 2.0 genes in this pathway |
MADAN DPPA4 TARGETS | 46 | 26 | All SZGR 2.0 genes in this pathway |
FORTSCHEGGER PHF8 TARGETS UP | 279 | 155 | All SZGR 2.0 genes in this pathway |